2 completed, 1 active not recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
Follow Alkylating Agents: new trials by email Literature Review of Alkylating Agents trials Research Report on Alkylating Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft Purified regulatory T-cells (Treg) plus CD34+ HSPC, Fludarabine, Melphalan - Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies | Phase 1 | Active not recruiting | Stanford University | 66 | 2021-09-07 | 2026-05-12 |
| Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck Cisplatin, Stereotactic Body Radiation Therapy (SBRT) - Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 20 | 2014-07-16 | 2023-01-19 |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer BIIB022 With Paclitaxel and Carboplatin - Non-Small Cell Lung Cancer | Phase 1 | Completed | Biogen | 18 | 2009-10-01 | 2013-09-16 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Laryngeal Diseases (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Squamous Cell Carcinoma of Head and Neck (1)
Biogen (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Stanford University (1)
United States (3)